Elite Diagnostic Limited (JMSE:ELITE)

Market Cap	537.17M
Revenue (ttm)	853.82M
Net Income (ttm)	32.02M
Shares Out	353.40M
EPS (ttm)	0.09
PE Ratio	16.77
Forward PE	n/a
Dividend	0.01 (0.67%)
Ex-Dividend Date	Sep 19, 2025

Volume	8,662
Average Volume	37,570
Open	n/a
Previous Close	1.500
Day's Range	1.500 - 1.520
52-Week Range	1.450 - 2.620
Beta	-0.20
RSI	48.90
Earnings Date	Nov 11, 2025

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company medical imaging services, including CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It also provides interventional procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In 2025, Elite Diagnostic's revenue was 853.82 million, an increase of 3.96% compared to the previous year's 821.28 million. Earnings were 32.02 million, an increase of 22.44%.